Literature DB >> 21157349

Update on fetal hemoglobin gene regulation in hemoglobinopathies.

Daniel E Bauer1, Stuart H Orkin.   

Abstract

PURPOSE OF REVIEW: The developmental switch from fetal to adult hemoglobin has long fascinated biologists and attracted hematologists given its importance for patients with hemoglobin disorders. New discoveries have reinvigorated the field of globin gene regulation. These results hold promise for improved treatment of the major hemoglobinopathies. RECENT
FINDINGS: Both genome-wide association studies and traditional linkage studies have identified several genetic loci involved in silencing fetal hemoglobin. BCL11A is a potent silencer of fetal hemoglobin in both mouse and humans. It controls the beta-globin gene cluster in concert with other factors. KLF1, a vital erythroid transcription factor, activates BCL11A and assists in coordinating the switch from fetal to adult hemoglobin. A regulatory network of cell-intrinsic and cell-extrinsic factors maintains the epigenetic homeostasis of the beta-globin cluster and accounts for the precise lineage-specific and developmental stage-specific regulation of the globin genes.
SUMMARY: With an improved understanding of pathways involved in the switch from fetal to adult hemoglobin, new targets have emerged for the treatment of the common hemoglobin disorders, sickle cell anemia and beta-thalassemia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21157349      PMCID: PMC3092400          DOI: 10.1097/MOP.0b013e3283420fd0

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  89 in total

Review 1.  RNAi therapeutics: principles, prospects and challenges.

Authors:  Lars Aagaard; John J Rossi
Journal:  Adv Drug Deliv Rev       Date:  2007-03-16       Impact factor: 15.470

2.  Developmental regulation of human fetal-to-adult globin gene switching in transgenic mice.

Authors:  T Enver; N Raich; A J Ebens; T Papayannopoulou; F Costantini; G Stamatoyannopoulos
Journal:  Nature       Date:  1990-03-22       Impact factor: 49.962

3.  Binding patterns of BCL11A in the globin and GATA1 loci and characterization of the BCL11A fetal hemoglobin locus.

Authors:  Kiran Jawaid; Karin Wahlberg; Swee Lay Thein; Steve Best
Journal:  Blood Cells Mol Dis       Date:  2010-06-12       Impact factor: 3.039

4.  Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster.

Authors:  S H Orkin; H H Kazazian; S E Antonarakis; S C Goff; C D Boehm; J P Sexton; P G Waber; P J Giardina
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

5.  BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies.

Authors:  Amanda E Sedgewick; Nadia Timofeev; Paola Sebastiani; Jason C C So; Edmond S K Ma; Li Chong Chan; Goonnapa Fucharoen; Supan Fucharoen; Cynara G Barbosa; Badri N Vardarajan; Lindsay A Farrer; Clinton T Baldwin; Martin H Steinberg; David H K Chui
Journal:  Blood Cells Mol Dis       Date:  2008-08-08       Impact factor: 3.039

6.  SCF induces gamma-globin gene expression by regulating downstream transcription factor COUP-TFII.

Authors:  Wulin Aerbajinai; Jianqiong Zhu; Chutima Kumkhaek; Kyung Chin; Griffin P Rodgers
Journal:  Blood       Date:  2009-04-28       Impact factor: 22.113

7.  5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia.

Authors:  T J Ley; J DeSimone; N P Anagnou; G H Keller; R K Humphries; P H Turner; N S Young; P Keller; A W Nienhuis
Journal:  N Engl J Med       Date:  1982-12-09       Impact factor: 91.245

8.  Transcriptional activation of the gamma-globin gene in baboons treated with decitabine and in cultured erythroid progenitor cells involves different mechanisms.

Authors:  Janet Chin; Mahipal Singh; Virryan Banzon; Kestis Vaitkus; Vinzon Ibanez; Tatiana Kouznetsova; Nadim Mahmud; Joseph DeSimone; Donald Lavelle
Journal:  Exp Hematol       Date:  2009-07-02       Impact factor: 3.084

9.  Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults.

Authors:  Swee Lay Thein; Stephan Menzel; Xu Peng; Steve Best; Jie Jiang; James Close; Nicholas Silver; Ageliki Gerovasilli; Chen Ping; Masao Yamaguchi; Karin Wahlberg; Pinar Ulug; Tim D Spector; Chad Garner; Fumihiko Matsuda; Martin Farrall; Mark Lathrop
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

10.  Genome annotation of a 1.5 Mb region of human chromosome 6q23 encompassing a quantitative trait locus for fetal hemoglobin expression in adults.

Authors:  James Close; Laurence Game; Barnaby Clark; Jean Bergounioux; Ageliki Gerovassili; Swee Lay Thein
Journal:  BMC Genomics       Date:  2004-05-31       Impact factor: 3.969

View more
  41 in total

1.  Fetal hemoglobin levels in African American and Hispanic children with sickle cell disease at baseline and in response to hydroxyurea.

Authors:  Katherine L Ender; Margaret T Lee; Sujit Sheth; Maureen Licursi; Jennifer Crotty; Sandra Barral; Nancy S Green
Journal:  J Pediatr Hematol Oncol       Date:  2011-10       Impact factor: 1.289

Review 2.  From stem cell to red cell: regulation of erythropoiesis at multiple levels by multiple proteins, RNAs, and chromatin modifications.

Authors:  Shilpa M Hattangadi; Piu Wong; Lingbo Zhang; Johan Flygare; Harvey F Lodish
Journal:  Blood       Date:  2011-10-12       Impact factor: 22.113

3.  Transcriptional environment and chromatin architecture interplay dictates globin expression patterns of heterospecific hybrids derived from undifferentiated human embryonic stem cells or from their erythroid progeny.

Authors:  Kai-Hsin Chang; Andy Huang; Hemei Han; Yi Jiang; Xiangdong Fang; Chao-Zhong Song; Steve Padilla; Hao Wang; Hongzhu Qu; John Stamatoyannopoulos; Qiliang Li; Thalia Papayannopoulou
Journal:  Exp Hematol       Date:  2013-08-28       Impact factor: 3.084

Review 4.  Fetal hemoglobin in sickle cell anemia.

Authors:  Idowu Akinsheye; Abdulrahman Alsultan; Nadia Solovieff; Duyen Ngo; Clinton T Baldwin; Paola Sebastiani; David H K Chui; Martin H Steinberg
Journal:  Blood       Date:  2011-04-13       Impact factor: 22.113

Review 5.  Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities.

Authors:  Andrew Wilber; Arthur W Nienhuis; Derek A Persons
Journal:  Blood       Date:  2011-02-14       Impact factor: 22.113

Review 6.  β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.

Authors:  Yelena Ginzburg; Stefano Rivella
Journal:  Blood       Date:  2011-07-18       Impact factor: 22.113

7.  Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping.

Authors:  Ivan Krivega; Colleen Byrnes; Jaira F de Vasconcellos; Y Terry Lee; Megha Kaushal; Ann Dean; Jeffery L Miller
Journal:  Blood       Date:  2015-05-15       Impact factor: 22.113

8.  Clinical phenotypes and the biological parameters of Congolese patients suffering from sickle cell anemia: A first report from Central Africa.

Authors:  Tite M Mikobi; Prosper Lukusa Tshilobo; Michel N Aloni; Pierre Z Akilimali; Georges Mvumbi-Lelo; Jean Marie Mbuyi-Muamba
Journal:  J Clin Lab Anal       Date:  2017-01-23       Impact factor: 2.352

Review 9.  Modulation of hepcidin as therapy for primary and secondary iron overload disorders: preclinical models and approaches.

Authors:  Paul J Schmidt; Mark D Fleming
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

Review 10.  EKLF/KLF1, a tissue-restricted integrator of transcriptional control, chromatin remodeling, and lineage determination.

Authors:  Yvette Y Yien; James J Bieker
Journal:  Mol Cell Biol       Date:  2012-10-22       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.